| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | DAVITA INC. CMN CLASS A | May 21, 2026 | |
| Buy | DaVita Inc. Common Stock | Mar 27, 2026 | |
| Sell | DaVita Inc. Common Stock | Sep 25, 2025 | |
| Buy | DaVita Inc. Common Stock [Me | Sep 23, 2025 | |
| Sell | DaVita Inc. Common Stock [Me | Sep 23, 2025 | |
| Buy | DAVITA INC CMN CLASS A | Dec 16, 2024 | |
| Sell | DaVita Inc. Common Stock | Dec 14, 2023 | |
| Sell | Davita Healthcare Partners I | Dec 12, 2023 | |
| Buy | DAVITA INC CMN | Jun 29, 2023 | |
| Sell | DaVita Inc. Common StockOpti | Jun 12, 2023 |
This page tracks congressional stock trading activity in DaVita Inc. (DVA) in the Healthcare sector. Disclosed Capitol has indexed 54 disclosed congressional trades involving DVA. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2026 — Disclosed Capitol has tracked 54 disclosed congressional trades in DaVita Inc. (DVA) — 23:21 sell-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 21, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Sep 25, 2025 | Julie Johnson | D | Sale | $1,001 - $15,000 |
| Sep 23, 2025 | Julie Johnson | D | Buy | $1,001 - $15,000 |
| Sep 23, 2025 | Julie Johnson | D | Sell | $1,001 - $15,000 |
| Dec 16, 2024 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Dec 14, 2023 | Jerry Moran, | R | Sale | $1,001 - $15,000 |
| Dec 12, 2023 | Thomas H Tuberville | R | Sale | $1,001 - $15,000 |
| Jun 29, 2023 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jun 12, 2023 | Thomas H Tuberville | R | Sale | $1,001 - $15,000 |
Across the 54 disclosed congressional trades in DaVita Inc. (DVA), members of Congress have reported 21 buys and 23 sells. The average 30-day alpha vs. the S&P 500 is 1.15%.
As of July 2026, corporate insiders at DaVita Inc. have filed 1 SEC Form 4 transaction in DVA over the past 12 months — including 1 sell worth $36.5M.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-07-31 | BUFFETT WARREN E | Sale | $36.5M |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
As of May 2026, DaVita Inc. has 111 federal contract award records on file from USAspending.gov — most recently $248K from the Department of Veterans Affairs on 2026-05-29.
| Award date | Agency | Amount |
|---|---|---|
| 2026-05-29 | Department of Veterans Affairs | $248K |
| 2026-05-13 | Department of Veterans Affairs | $3.8M |
| 2026-05-11 | Department of Veterans Affairs | -$65K |
| 2026-03-10 | Department of Veterans Affairs | -$130K |
| 2026-01-29 | Department of Veterans Affairs | $25.1M |
| 2026-01-26 | Department of Veterans Affairs | $632K |
| 2025-12-17 | Department of Veterans Affairs | $121.4M |
| 2025-11-13 | Department of Veterans Affairs | $26.9M |
| 2025-10-21 | Department of Veterans Affairs | -$170K |
| 2025-10-16 | Department of Veterans Affairs | $26.8M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, DaVita Inc. reported revenue of $13.64B and net income of $746.8M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $3.55B, net income $265.4M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.